IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that CEO Josh Riggs will be presenting a corporate overview at the upcoming Sequire Investor Summit 2024. The conference is scheduled for January 23-25, 2024 at the Condado Vanderbilt Hotel in San… Read More..

Mr. McCarrey brings a strong track record of success and deep experience in regenerative medicine markets POMPANO BEACH, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces… Read More..

The Company will Showcase the product at Booth 52029 in the Venetian Expo Hall from January 9 - 12, 2024 LAS VEGAS, NV / ACCESSWIRE / January 9, 2024 / SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive platform technology company with 77 pending… Read More..